• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

Japan’s Shionogi says Phase 3 study showed COVID pill reduces transmission

by October 29, 2024
written by October 29, 2024

TOKYO (Reuters) – Japan’s Shionogi & Co said on Tuesday a global, late-stage study showed its pill-based treatment for COVID-19 was effective in reducing transmission of the disease.

Ensitrelvir, known commercially as Xocova, showed a statistically significant reduction in participants with symptomatic infection after exposure to household contacts with COVID, Shionogi said in a statement.

The Phase 3 SCORPIO-PEP trial involved about 2,400 participants in the United States, South America, Africa, and Asia.

The result follows the drugmaker’s May comments that its SCORPIO-HR trial showed the pill failed to reduce common symptoms of the illness, compared to a placebo.

Japan gave the drug full approval in March this year. Although the government bought 2 million courses of the treatment during the pandemic, most of the supply was unused and set to be destroyed, media said.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
Asian stocks mixed, dollar drifts before megacap earnings, jobs data
next post
Santander books record quarterly profit on retail unit, delays UK results

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Fill Out & Get More Relevant News








    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • Divided Fed proposes rule to ease capital requirements for big Wall Street banks

      June 26, 2025
    • Women’s Tennis Association extends media rights deal with Tennis Channel through 2032

      June 26, 2025
    • Bumble shares jump 26% as dating company plans to axe 30% of workforce

      June 26, 2025
    • Small-business AI use is lagging, but one firm is channeling Sherlock Holmes and knocking out ‘grunt work’

      June 25, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (534)
    • Stock (6,426)

    Latest News

    • Divided Fed proposes rule to ease capital requirements for big Wall Street banks
    • Women’s Tennis Association extends media rights deal with Tennis Channel through 2032

    Popular News

    • Gold and Silver: New Weekly Lows and Potential Targets
    • Germany’s Scholz to call confidence vote, sees snap election in March

    About The Significant deals

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy